Significant UK variations between hospitals in adverse outcomes for DCIS
Significant UK variations between hospitals in adverse outcomes for DCIS
EBCC 2014 key messages to doctors
Comment: Radiotherapy after mastectomy for breast cancer that has spread to just a few lymph nodes
Radiotherapy after mastectomy benefit for breast cancer that has spread to just a few lymph nodes
PSA as a marker of disease in patients with prostate cancer and bone metastases
ALSYMPCA trial: Ra-223 effective and well-tolerated for CRPC with symptomatic bone metastases
Maximizing survival in metastatic castration-resistant prostate cancer (mCRPC)
Maximizing survival in metastatic Castration-Resistant Prostate Cancer: panel discussion
Symptom management and quality of life in metastatic breast cancer
Radiation in the treatment of the axilla in neoadjuvant chemotherapy for breast cancer
Breast cancer psychosocial and survivorship issues: are we doing better?
New therapy aspects for myeloid chronic lymphoma